Privi Overview

  • Founded
  • 2014
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A

Privi General Information


Developer of a medical device intended to alleviate pain caused by hemorrhoids. The company's device helps to alleviate and reduce the recurrence of bleeding and painful symptoms caused by hemorrhoids, thereby enabling patients to get cured without any side effects.

Contact Information

Ownership Status
Financing Status
Formerly VC-backed
Primary Industry
Therapeutic Devices
HeMo Bioengineering
Primary Office
  • AStart Central
  • Blk 79 Ayer Crescent Drive, Number 05-03
  • Singapore, 139955
  • Singapore
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Privi Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 28-Oct-2021 00000 Completed Generating Revenue
2. Early Stage VC 00000 00000 Completed Startup
1. Grant 01-Dec-2014 $77.1K Completed Startup
To view Privi’s complete valuation and funding history, request access »

Privi Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
NTUC Income Corporation Minority 000 0000 000000 0
To view Privi’s complete investors history, request access »